Ionis Pharma Urges Investors to Reject the Below-the-Market Offer By Post author:Sam Post published:August 23, 2017 Post category:BioPharma August 24, 2017By Mark Terry… Source: BioSpace You Might Also Like Boston's Anti-Aging Startup resTORbio Scores $40M November 29, 2017 Dentsply Sirona Chairman, CEO and COO Resign in Management Shakeup October 3, 2017 Founding CEO of Editas Medicine Lands New Gig at Top Biotech VC Firm May 31, 2017
